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Foreword
A workshop  on  `Ticks and Tick-borne Disease Control’ was  held  in Kampala,
Uganda, from 12–14 September 1991. This was the fourth workshop in a series
designed to bring together scientists and those responsible for tick-borne disease
control in countries of eastern, central and southern Africa to discuss recent research
findings applicable to these diseases and to address problems encountered in their
control. The first two workshops in the series were held in Nairobi, Kenya, in 1984
and 1985 and were organized jointly by the International Laboratory for Research on
Animal Diseases (ILRAD) and the Food and Agriculture Organization of the United
Nations (FAO). The third workshop was held in Lilongwe, Malawi, in September
1988 and, together with this Kampala workshop,  was  organized  jointly by the
Inter-African Bureau of Animal Resources of the Organization of African Unity
(OAU-IBAR), FAO and ILRAD. The Kampala workshop was timed to coincide with
the annual review meeting of the FAO national and regional projects. The Government
of Uganda convened an additional meeting on this occasion to address the specific
tick and tick-borne disease problems in Uganda. Many of those who participated in
the OAU/FAO/ILRAD workshop also participated in the Uganda meeting that fol-
lowed.
The Government of Uganda gave the workshop and related meetings high priority
and considerable support. We were honoured by the attendance of Dr. Samson
Kisseka, the Vice President, Mrs. Victoria Sekitoleko, Minister for Agriculture,
Animal Industry and Fisheries, and Dr. Speciosa Kazibwe, Minister for Women,
Youth and Culture, an introductory address from His Excellency President Y.K.
Museveni and a closing address from Mr. J.O. Bwangamoi, Deputy Minister for
Agriculture, Animal Industry and Fisheries. The workshop was organized by a
committee composed of Drs. Tom Dolan (ILRAD), Fred Musisi (FAO, Malawi),
Jamlack Mutugi (FAO, Uganda), Charles Otim (Uganda) and Jotam Musime (OAU-
IBAR). The Government of Uganda was extremely helpful in facilitating the arrange-
ments for the workshop and meetings. Dr. Musime coordinated the workshop through
the OAU-IBAR office in Nairobi, while Drs. Mutugi and Otim made arrangements
for facilities and accommodation in Kampala. I am particularly grateful to Dr. Tony
Musoke who facilitated the early interactions with different ministries, Makerere
University and research workers in Uganda, and to Mr. Kepher Nguli for providing
logistical support from Nairobi and for making travel arrangements for ILRAD-sup-
ported participants.
The Lilongwe workshop recommended that topics to be discussed at the next
workshop should include tick-borne diseases other than theileriosis, in addition to
country reports. The program reflected this recommendation, with papers presented
on current and future methods of diagnosis, novel vaccines for tick-borne diseases
and vaccines against ticks. Papers were also given on computer models and the
assessment  of  impact  and economics of  disease control.  Papers were  given  by
representatives from OAU, FAO, the Southern African Development Co-ordination
Conference (SADCC) and ILRAD on strategies for tick and tick-borne disease
control and interactions within the region. The country reports are in general short
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summaries of the work done since the previous workshop. A detailed report is
presented on the work in Eastern Zambia (by Lynen, Makala and Pas) because of the
large-scale immunization conducted, the approach to vaccine delivery used, and the
analysis and interpretation of results. A new element of the workshop was the
selection of a special topic for focused discussion. Diapause was chosen because it
had been the subject of recent publications in which its nature and importance in the
epidemiology of theileriosis were addressed. A panel composed of Drs. Dirk
Berkvens, Andy Norval, Rupert Pegram and Alan Young led the discussion and some
25 participants listened to or joined in the debate. Each session was followed by a
discussion, and recommendations were drafted and agreed in the final session.
The recommendations made by the Lilongwe workshop relating to parasite no-
menclature and definitions of disease reactions have been widely referred to and
adopted. At this workshop the most significant recommendation was that of setting
up a committee with responsibility to draft new standards for live vaccines for
tick-borne diseases. The committee’s responsibility will be to submit draft standards
for consideration by OAU, FAO and ILRAD. If approved, they will be forwarded
through appropriate channels for ultimate approval by the Standards Committee and
member countries of the Office International des Epizooties (OIE).
Participation at the workshop was sponsored by the governments of Belgium and
Uganda, the Overseas Development Administration of the United Kingdom, FAO, the
International Centre of Insect Physiology and Ecology (ICIPE), ILRAD and OAU.
Social functions were organized by the Government of Uganda, FAO and ILRAD and
the series of meetings was given considerable attention on television, radio and in the
Press.
Initial reports and summaries of the proceedings were typed during the workshop
by the meeting secretariat. The corrected and edited versions were typed by Ms. Susan
Nduta at ILRAD. Mr. Peter Werehire, ILRAD, prepared the camera-ready pages for
publication.
Thomas T. Dolan
International Laboratory
for Research on Animal Diseases
Nairobi, April 1993
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Opening address
His Excellency President Y.K. Museveni
President of Uganda
It is my great pleasure to be with you this morning to address you at the opening
ceremony of the Government of Uganda workshop on the control of ticks and
tick-borne diseases.
Ladies and gentlemen, I am particularly happy to see that you are gathered here to
address yourselves most seriously to issues relating to the control of ticks and the
most economically important group of diseases transmitted by them, namely East
Coast fever, babesiosis, anaplasmosis and heartwater.
The importance of ticks and tick-borne diseases, and indeed of the meeting itself,
is clearly demonstrated by the presence of a rich mixture of scientists with a deep
knowledge and wide and invaluable experience in their areas of specialization who
are here to identify, discuss and finally recommend yet newer approaches in the
continuing effort in the fight against ticks and tick-borne diseases.
It is therefore my strong conviction and belief that at the conclusion of your
deliberations, you will have come up with ideas and strategies, based on scientific
facts, for the drawing up of a master plan which should provide both policy makers
and those who implement with clear guidelines and direction for the effective and
sustainable control of ticks and, therefore, tick-borne diseases. Such guidelines and
the measures which you are going to recommend should be efficient, cost-effective
and, above all, practical in the context of the economic, climatic and ecological factors
prevailing in Uganda.
I would also like to advise further that your discussions should equally take into
consideration the diverse characteristics, practices or behaviour of the farming
community to which the recommendations apply and that the farmers themselves are
by and large resource-poor.
The sole effective method of controlling ticks in this country has been, for a long
time, the employment of acaricides by direct application to the animal and may
remain so for at least some years in the foreseeable future. Associated with this
method however are a number of problems, namely (i) poor sustainability, as a result
of the ever rising prices for chemicals and the high cost of labour and inputs; (ii)
unwanted chemical residues in animal products; (iii) environment pollution; and (iv)
tick resistance.
The problem of sustainable livestock husbandry, however, is not new, but the
biggest dilemma is its huge dimensions. To maintain an economic livestock produc-
tion level therefore, in the presence of the endless challenges and constraints such as
are posed by the problem of control of ticks and tick-borne diseases, requires a
dedicated and tireless effort by a community of scientists like these gathered here, to
constantly review the situation and exchange ideas with the objective of introducing
new and innovative methods of control of, for instance in our situation, East Coast
fever.
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I should therefore say that the present workshop is being conducted at the right
time. It is the right time because the need is high to review and update or modify our
approaches and strategies for the control of tick-borne diseases to put them in line
with the latest developments in knowledge.
I understand that a vaccine against East Coast fever was developed at the East
African Veterinary Research Organization laboratory at Muguga, Kenya, and that
presently it is being evaluated through field trials by many countries in East, Central
and Southern Africa. I also learnt that a similar exercise to establish the efficacy of
the vaccine against our own strains of the causal organisms of East Coast fever is
being undertaken by scientists at the Animal Health Research Centre, under the joint
financial support of the Danish and Ugandan governments. We are eagerly looking
forward to the outcome and conclusions from the study but also hope that any of the
findings and observations which may be available so far shall be adequately discussed
in the present workshop. I must express my thanks to the Danish Government for the
support, and the Food and Agriculture Organization for their executing role in this
project.
Ladies and gentlemen, you will know that the key figure in the transmission of
East Coast fever, babesiosis, anaplasmosis and cowdriosis is of course the tick itself.
It is therefore pertinent that, in your deliberations, due attention be given to the
relevant aspects of controlling the tick. Even with the availability of prophylactic
treatment for some of the tick-transmitted diseases, tick infestations on cattle will
still have to be controlled, or kept at low levels, perhaps using a strategic dipping
approach.
It should also be our ultimate wish and desire that a vaccine to protect cattle against
ticks, or at least against some of those ticks which are responsible for the major
diseases, may also be found by our sister laboratories with greater research capacities
and facilities.
Madam Chairperson, let me take this opportunity to thank all the agencies who
have at one time or another rendered to us assistance in the continuing effort to control
livestock diseases both in the laboratory and in the performance of field programs.
Special thanks in this respect, go to FAO, DANIDA, EEC, GTZ, UNDP, the World
Bank, OAU-IBAR, WHO, IAEA and IFAD.
I would also like to recognize with deep appreciation the collaborative roles with
our national livestock research institutions played by the International Laboratory for
Research on Animal Diseases, the International Centre of Insect Physiology and
Ecology and the Free University of Berlin.
I would like to thank all of you, and particularly our distinguished delegates from
abroad, for having spared your time to come to this very important meeting. I also
thank the organizers for the excellent arrangements which have made this meeting a
success.
I hope the workshop will consider in detail all available but suitable alternatives
of ticks and tick-borne diseases for Uganda, for the sustainable benefits of our
livestock industry.
I wish you fruitful deliberations.
I now have the pleasure to declare the workshop open.
Thank you very much.
OPENING ADDRESS
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Address by the Food and Agriculture
Organization Representative in Uganda
A.A. Khalil
P.O. Box 521
Kampala, Uganda
It gives me great pleasure to see such a large gathering of scientists, senior govern-
ment workers and experts in the field of tick and tick-borne diseases. I understand 13
countries of the region are represented. Various directors of veterinary services
represent their countries while the ticks and tick-borne disease projects are repre-
sented by the chief technical advisers (CTAs) and the national project directors. There
are many other scientists and experts from a number of interested institutions like the
International Laboratory for Animal Diseases (ILRAD). The Organization of African
Unity’s Inter-African Bureau for Animal Resources is represented by the Director,
among others. We have also in the gathering senior technical and operation officers
from the Food and Agriculture Organization’s headquarters in Rome.
There is no doubt that this must surely be the most distinguished gathering of our
animal and veterinary scientists ever seen. I am particularly pleased that the partner-
ship of FAO, OAU-IBAR and ILRAD is almost complete in terms of having the
critical human resources in tackling this tick-borne disease menace.
The Food and Agriculture Organization on its part has funded and executed many
projects in the East, Central and Southern African region. Our experts were involved
in the development of the only available method of East Coast fever immunization,
some 25 years ago, and I am made to understand that some of you represented here
worked and participated in the development and refinement of the method. My main
purpose is not to praise your great effort but to challenge you to produce even better
results. For this we can only turn to you and tell you that the member states of the
United Nations view your deliberations over the next few days with great interest.
The implementation of the various projects can only happen, at least for now,
through donor funding. Many agencies, both multinational and bilateral, have con-
tributed in this area. I would, though, like to specifically thank the Kingdom of
Denmark for funding so many of the projects in the region concerned with tick-borne
diseases. Our own project in this country is part of this FAO/DANIDA partnership.
Finally, for all of us with an interest in enhancing food production and particularly
animal protein, we wish the experts and policy makers gathered here the best of
success and a very fruitful deliberation. Remember, we are seeking solutions for this
problem not tomorrow, but today. Thank you.
ADDRESS BY FAO REPRESENTATIVE
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COUNTRY REPORTS
East Coast fever immunization in Burundi
G. Nigarura
Central Veterinary Laboratory
P.O. Box 227
Bujumbura, Burundi
Immunization against East Coast fever (ECF) in Burundi began in 1981 with the
preparation of local stabilates of Theileria parva at the Central Veterinary Laboratory,
Bujumbura, with technical assistance from the German Agency for Technical Coop-
eration (GTZ) and the International Laboratory for Research on Animal Diseases
(ILRAD). The original stabilates contained three local isolates—Gatumba, Gitega
and Ngozi. The Ngozi isolate was later deleted due to its apparent association with
ophthalmic problems. The present locally produced Burundi stabilates have been
used on a small scale with satisfactory results since the early 1980s. The target group
of animals has always been cross-bred (Ankole and exotic) calves and to a lesser
extent pure exotic calves between 2 and 12 months of age.
The Burundi stabilates were evaluated from 1981 through 1985 and 402 calves
were immunized during  this  time. Three  government farms  participated in this
activity while only 10% of the calves were owned by private farmers. From 1986, the
number of government farms and livestock projects on which ECF immunization has
been used has increased to seven, while private cattle owners constituted 30 percent
of total participation within the program. From 1986 through July 1991, 1781 calves
were immunized.
The FAO/DANIDA project GCP/BOF/022/DEN evaluated the Malawi-produced
trivalent T. parva (ECF) stabilate vaccine in Burundi during 1990 to test its ability to
protect cross-bred calves against disease when challenged with the Burundi T. parva
stocks. The results to date have been negative but not conclusive and a second
immunization trial using the Malawi-prepared stabilates is proposed for early 1992.
This is in an attempt to provide the Burundi Government with an alternative to their
locally produced Burundi stabilates which could be of value in the future if local
production of the Burundi stabilates has to be suspended for any reason.
The immediate livestock development objective for Burundi is to increase animal
production by cross-breeding local cattle with higher producing exotic stock. This
will require a much larger scale of ECF immunization in the immediate future. The
present program of immunization must be expanded and improved to support this
need. The Burundi Government recognizes that it will require outside help to support
this activity which will involve further training of veterinary personnel, assistance
with stabilate production and logistical support. Immediate plans must be made to
provide this assistance to the variety of livestock improvement programs that are
planned.
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East Coast fever immunization in Malawi
S.P. Kamwendo*, J.G.M. Msiska* and F.L. Musisi†
*Central Veterinary Laboratory
P.O. Box 527
Lilongwe, Malawi
†ECF Vaccine Production and Quality Control Project
P.O. Box 30750
Lilongwe 3, Malawi
East Coast fever (ECF) immunization in the field started in 1984 soon after extensive
field trials which confirmed the protection and safety of the `Muguga Cocktail’
against local Malawi strains of Theileria parva. Immunizations were limited to exotic
cattle and their crosses in government and private farms and in the milk shed areas
of Lilongwe and Mzuzu in the central and northern regions, respectively. Present
knowledge suggests that local zebu cattle, which are under intensive tick control,
develop enzootic instability. Therefore, it would be prudent to consider such herds
for immunization. East Coast fever immunization is now being followed by immuni-
zation against the other tick-borne diseases, babesiosis, anaplasmosis and heartwater,
as a routine.
The vaccine institute in Malawi has the capacity to satisfy the demands for Malawi
and other ECF-affected countries. The institute has supplied vaccines and reagents
to Burundi, Tanzania, Uganda and Zambia, and there is collaborative research with
countries such as Zimbabwe and Zambia and with the International Laboratory for
Research on Animal Diseases (ILRAD).
The real benefits from ECF immunization can only be assessed when the basic
production losses attributed to ECF are known. Baseline data on production and
fertility is being generated from areas where cattle have been immunized.
The production of the vaccines will continue while efforts are made to improve on
quality and delivery. External assistance is being sought in support of the vaccine
production laboratory.
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Tick and tick-borne diseases: recent
developments in Mozambique
M. Mazibe* and M. Asselbergs†
*National Veterinary Institute
P.O. Box 1922
Maputo, Mozambique
†Veterinary Faculty
Eduardo Mondlane University
P.O. Box 257
Maputo, Mozambique
Mozambique is bordered by six countries: Tanzania, Zambia, Malawi, Zimbabwe,
South Africa and Swaziland. Each of these countries has a different situation in terms
of ticks and tick-borne diseases as compared to Mozambique. In Mozambique, ticks
and tick-borne diseases are known as important constraints to livestock improvement.
The most important tick vectors are: Amblyomma hebraeum, A. variegatum, Boophi-
lus microplus, B. decoloratus, Rhipicephalus appendiculatus and R. evertsi. The
diseases transmitted by these ticks which are present throughout the country are
heartwater, babesiosis, anaplasmosis and theileriosis considered to be caused by T.
mutans. East Coast fever however has only been identified clinically in the northwest
Angonia District and once in cattle of Morrumbala District in Zambezia Province.
The Southern African Development Coordination Conference (SADCC) training
course on major vector-borne livestock diseases (Swaziland, August 1990) formu-
lated recommendations immediately relevant to the Mozambican situation, empha-
sizing the need for an epidemiological unit studying tick-borne diseases, their impact
and different control methods.
In Mozambique a joint team from the National Veterinary Institute and the
Veterinary Faculty, Eduardo Mondlane University, has established an indirect fluo-
rescent antibody test (IFAT) for Babesia and has gained some experience with the
same test for Cowdria with antigen supplied by the SADCC research project in
Harare. One veterinarian has been trained in Harare to culture Cowdria and the author
will participate in a training course in October 1991. The same team is currently
producing vaccines against Babesia and Cowdria on a small scale.
Sera from cattle and goats from all provinces and types of management have been
tested once. A card test for anaplasmosis has been applied on a limited scale using a
commercial antigen. Serological results showed titres against Babesia and Cowdria in
all provinces and most types of management. However, large differences in the percent-
age of positive titres in different herds and/or provinces were found. This implies that
movement or importation of cattle often represent hazards of tick-borne diseases.
In contrast to countries where ECF is endemic, as in some neighbouring countries,
the situation in Mozambique is not so clear and needs to be investigated. The vector
COUNTRY REPORTS
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R. appendiculatus is found throughout the country, but the disease has been detected
only in Angonia. However, in sera from the south, titres against T. parva were found
in low numbers of cattle by Jacobsen (1985) using the IFAT and again using an ELISA
(unpublished results).
In the near  future cattle movement inside the country  and importation from
neighbouring countries can be expected and it is therefore urgent to define the real
prevalence of T. parva in Mozambique and the possible carrier state of cattle to be
introduced. Presently we do not have the capacity to perform these tests.
REFERENCE
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Immunization against East Coast
fever in Rwanda
S. Mbarubukeye
Laboratoire Veterinaire National de Rubirizi
P.O. Box 804
Kigali, Rwanda
East Coast fever (ECF) is the major disease causing mortality in cattle in Rwanda,
particularly in exotic pure breeds and their crosses with the indigenous Ankole breed.
Immunization against ECF began during the FAO Tick Control Project (1977–1982)
and a study was carried out to assess the distribution of the disease and to identify
the species and strains of Theileria involved. Theileria parva and T. mutans were
found to be responsible for 49% and 43% of theileriosis cases, respectively. The
disease was diagnosed throughout the country, except in the northern (mountainous
regions) where high altitude and low temperature limit the distribution of the theil-
eriosis vectors, Rhipicephalus appendiculatus and Amblyomma variegatum. The
local Ankole breed appears to be tolerant to these diseases.
During the FAO project, technicians were trained to perform ECF vaccination and
monitoring. After the end of the project, the program of ECF immunization was taken
over by the National Veterinary Laboratory at Rubirizi. To date, two strains of T.
parva, T. parva Nyakizu and T. parva Satinski, isolated in the southern and central
parts of the country, are being used.
An average of 300 head of cattle are vaccinated each year on a voluntary basis.
Even though the percentage of serious reactions after vaccination is not above five
percent, many farmers are reluctant to vaccinate cattle because of the risk of reaction
and mortality, the high cost of vaccination (approximately US$ 10), the lack of trained
staff to monitor vaccinated cattle in rural areas and the general unavailability, and
expense, of long-acting tetracyclines, parvaquone (Clexon, Coopers) and halofugi-
none (Terit, Hoechst). Another constraint to the more widespread use of vaccination
is that the National Veterinary Laboratory lacks qualified staff. The laboratory would
benefit from support from specialized institutes, such as the International Laboratory
for Research on Animal Diseases (ILRAD), and from the FAO/DANIDA projects
working on tick-borne disease control in the region.
COUNTRY REPORTS
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Ticks and tick-borne diseases in the Sudan
O.M. Osman
Veterinary Research Administration
Ministry of Agriculture, Natural and Animal Resources
P.O. Box 8067
Khartoum, Sudan
In Sudan 72 tick species have been identified, 14 of which infest livestock and five
are vectors of very common tick-borne diseases. Hyalomma anatolicum is the vector
of Theileria annulata which causes a 30% calf mortality in exotic dairy herds, T. hirci
which causes high mortality in sheep and Babesia equi which causes equine babe-
siosis. Rhipicephalus evertsi transmits T. hirci and is a potential candidate for T.
annulata transmission. Boophilus species transmit cattle babesiosis and anaplas-
mosis. Amblyomma lepidum and A. variegatum transmit heartwater in sheep. Recent
outbreaks of heartwater in cattle have been reported. Theileria parva, transmitted by
Rhipicephalus appendiculatus, occurs in the southern part of the country (see follow-
ing paper by I.I. Julla).
Ticks and tick-borne diseases have become very significant problems in the
modern production sector and in breed improvement programs. Tick infestation is
also considered important in cattle and sheep because it causes debilitation, teat
damage, hides and skin damage. Cases of camel paralysis have also been reported.
A strategy of chemical tick control will be adopted in the modern animal produc-
tion sector, in the developing milk sector in irrigation schemes and in the nomadic
cattle to reduce tick infestation to minimal levels.
COUNTRY REPORTS
7
Progress in research on theileriosis
in Equatoria State, Sudan
I.I. Julla
University of Juba
c/o Faculty of Veterinary Science
P.O. Box 32
Khartoum North, Sudan
Epidemiological studies carried out in Equatoria State, Sudan, confirmed the pres-
ence of Theileria parva, the causative agent of East Coast fever (ECF) and the vector
tick, Rhipicephalus appendiculatus. The disease affects the local breeds of cattle,
especially the calf crop, causing a mortality of 80–100% (Morzaria et al., 1981; Julla
et al., 1989). As a result, a joint project between the Directorate of Animal Resources,
Equatoria State, and the University of Juba was established in 1987 with the following
objectives: to develop a research program on theileriosis and related tick-borne
diseases, babesiosis, cowdriosis and anaplasmosis and to develop means of control
for T. parva through vaccination by the infection-and-treatment method.
The project activities have been divided into three phases.
1. Epidemiological studies.
2. Isolation and characterization of T. parva parasites present in the area.
3. Examination of the isolated and characterized parasites as immunizing strains
using the infection-and-treatment method.
The project has established basic laboratory facilities at Juba University. The
Norwegian Agency for Development Co-operation (NORAD) has assisted the project
with funding for equipment and chemicals. The International Laboratory for Re-
search on Animal Diseases (ILRAD) is supporting the project with technical advice,
research collaboration and training. The project should allow Sudan (Equatoria State)
to develop improved control measures for theileriosis and other tick-borne diseases.
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East Coast fever immunization
trials in Uganda
J.J. Mutugi and C.P. Otim
Animal Health Research Centre
P.O. Box 24
Entebbe, Uganda
Three immunization trials against East Coast fever (ECF) were carried out in
Lusenke, Mbarara and Sironko, representing central, western and eastern regions,
respectively. The sites were in areas where ECF and other tick-borne diseases are a
major problem. The primary objective of the trials was to evaluate the protection
afforded by the trivalent Theileria parva stabilate vaccine produced in Malawi against
challenge by Theileria parva parasites occurring in Uganda. The first trial in Lusenke
gave broad indications that the trivalent vaccine was protecting cattle against the
natural field T. parva challenge. However, a full and comprehensive assessment of
this protection was complicated by the occurrence of other tick-borne diseases.
In the second trial in Mbarara District, Western Region, animals were immunized
against T. parva, Anaplasma marginale, Babesia bigemina, B. bovis and Cowdria
ruminantium before field exposure. The vaccinations were carried out in the follow-
ing sequence:
1. Immunization of cattle using the trivalent stabilate vaccine stocks (22 January
1991). At the same time a number of cattle which were found to contain
antibodies to T. parva following natural infection were challenged with the T.
parva trivalent stabilate vaccine to test the protection against the vaccine
stocks.
2. Homologous challenge of the immunized cattle to ascertain immunity (26
February 1991).
3. Vaccination of cattle against Cowdria ruminantium (9 April 1991).
4. Vaccination of cattle against Anaplasma and Babesia (21 May 1991).
5. Exposure of cattle to field challenge (15 July 1991).
A total of 67 cattle consisting of 18 pure-bred Friesian bulls and 49 cross-breds of
exotic and Ankole types were selected for the trial.
(a) Fifty cattle with no antibodies to T. parva in the indirect immunofluorescent
antibody  test were  immunized  using the  trivalent stabilate  stocks. These
included the 18 Friesian bulls.
(b) Seventeen cattle which had antibodies to T. parva from local T. parva infec-
tions were challenged directly with the trivalent vaccine parasites.
The results from the immunization, challenge and exposure phases of the trials
were as follows:
1. Following immunization, a majority of the cattle, 37 out of 50 (74%), serocon-
verted to T. parva after inapparent reactions. Nine (18%) reacted mildly, and
three (6%) had moderate to severe reactions. Seventeen out of the 17 antibody-
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positive cattle challenged directly with the trivalent vaccine stocks underwent
inapparent reactions indicating cross-protection between the trivalent vaccine
stocks and the local T. parva parasites to which the cattle had been exposed.
2. Homologous challenge confirmed immunity of the immunized cattle with 48
out of 50 cattle showing inapparent reaction to challenge.
3/4. The Cowdria, Anaplasma, Babesia vaccination produced few reactors with a
small proportion of the immunized Friesian cattle showing a transient fever.
5. The 67 cattle putatively protected against ECF by the trivalent vaccine and 10
susceptible controls were grazed in two large paddocks where ECF was known
to be present. The cattle were not subjected to any form of tick control for over
60 days and the experiment is continuing.
The results to date show that tick challenge was moderate but T. parva
infection was detected. Many cattle had detectable schizonts and all had a low
piroplasm parasitaemia. One control animal died of acute T. parva infection.
Two out of the 67 immunized cattle died of T. parva with very low schizont
parasitoses, but with a post mortem picture indicative of buffalo-derived T.
parva infection. Three other cattle, all Friesian, died of complications with
Lumpy Skin Disease.
An analysis of results to date showed that 82% reacted inapparently,
14.9% had mild reactions, 2% had moderate reactions and 5.9% had severe
reactions.
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East Coast fever immunization
in Tanzania Mainland
G.L. Komba and J.G.M. Mundogo
Ministry of Agriculture and Livestock Development
P.O. Box 9152
Dar es Salaam, Tanzania
Tanzania was included in the second phase of the FAO/DANIDA projects for East
Coast fever (ECF) immunization in East and Central Africa and, after more than a
ten-year interruption, ECF immunization field trials have been recommenced. Project
activities started in June 1990 and have been restricted to the southern highlands in
the Iringa and Mbeye regions.
East Coast fever is seen as the major hindrance to a rapid increase in the keeping
of improved milk cattle in the small-holder sector. The government is supporting the
small-holder sector by providing cross-bred heifers from livestock multiplication
centres. In these centres, tick control is very strict. The in-calf heifers sold to the
small-holders are therefore at high risk to ECF (and other tick-borne diseases) when
they leave the centres and they are the main target group for immunization.
Three trials have been conducted each involving 20 animals immunized using the
trivalent Theileria parva stabilate vaccine produced in Lilogwe. At the same time,
approximately 650 heifers have been vaccinated and 120 of them have been distrib-
uted to small-holders.
The results of the trials have been positive. Monitoring of cattle following immu-
nization using regular weighing has shown that production parameters are not
affected by the immunization procedure. Clinically, transient fevers and lymph node
swellings have been noted. Lymph node biopsies revealed few or no schizonts. Serum
conversion rates have been satisfactory with over 90% developing antibodies in all
three trials. In the first two trials, immunized and control animals were exposed to
unlimited tick challenge. In the first trial, in which exposure took place in February
1991, the Rhipicephalus appendiculatus tick burden was very high, reaching a mean
of 240 ticks per ear. The cattle reacted with fever and oedematous swelling in the
head, ears and neck. Anaplasma and Babesia parasites were seen in blood smears 15
days after exposure. These parasites were thought to be of vaccine origin as the
animals were immunized with these parasites and tick transmission was unlikely as
the time was too short after vaccination. The result of the first trial was that five of
the 20 immunized animals died of ECF. Eleven of the controls also died, the last one
had to be sacrificed as it became blind due to a chronic ECF infection.
The second trial exposure was to R. appendiculatus nymphs and six out of eight
controls showed clinical ECF and three died in spite of treatment. The 20 immunized
animals showed various degrees of fever, some of up to nine days’duration. Schizonts
were detected in most animals. One of the 20 animals died of ECF.
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In the third trial 20 animals were immunized and subjected to partial tick control.
They are being monitored at regular intervals and the main herd is serving as control.
No case of ECF has been detected in this herd and the trial is continuing.
Although results of the first trials do not show 100% protection, it is thought that
the method is valuable and economically feasible for the target group of animals.
Tanzania’s need for vaccine in the future might approach 40,000 doses annually,
provided that a realistic price can be found for the immunization.
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East Coast fever immunization
in Pemba, Tanzania
J. de Boorder
Smallholder Livestock Development Project
P.O. Box 368
Chake Chake
Pemba, Tanzania
Preliminary trials showed that immunization using a local isolate of Theileria parva
was possible. A decision was taken to begin immunizing a specific group of animals,
the F1 Jersey/zebu cross-breds, at as early an age as possible using the T. parva
(Pemba/Mnarani) stabilate (2913) and treatment with buparvaquone (Butalex, Pitman
Moore Ltd.). This drug was chosen because a single injection was likely to be
effective in controlling the immunizing infection. As the cross-breds are owned by
smallholder farmers on farms scattered over the whole island it would mean savings
on travel expenses and time when compared to the two injections required if
oxytetracycline was being used.
Approximately 100 animals of about two months of age were immunized with a
1/10 dilution of the stabilate and buparvaquone. Sera were collected on the day of
immunization and on day 30. Seroconversion on day 30 was found to be low and
variable, so it was assumed in most cases that immunization was unsuccessful. The
cause of this was first thought to be the stabilate diluent which, due to erratic
electricity supply, was often thawed and frozen inadvertently before use. It is likely
that the stabilate diluent lost its buffering capacity and the altered pH had an adverse
effect on the sporozoites.
In March 1991 fresh stabilate diluent was obtained and immunization was started
using either buparvaquone on day 0 or two doses of oxytetracycline, on day 0 and
day 3. Seroconversion was markedly better with oxytetracycline immunization of 25
calves, 75% were positive to T. parva schizont antigen in the indirect immunofluo-
rescent antibody test at a dilution of 1/1000 or higher compared to less than 20% for
the buparvaquone group. This suggests that buparvaquone with its schizontcidal
activity is not suitable for immunization.
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Field East Coast fever
immunization in Ungunja, Tanzania
A.R. Rabia, J. Sevar, J.A. Ocama, P. Rushigajiki, S. Adam, A. Omar and H. Omar
Department of Livestock Development
P.O. Box 159
Zanzibar, Tanzania
Following a series of trials testing immunization against East Coast fever (ECF) using
locally isolated parasites conducted jointly by the government, the International
Laboratory for Research on Animal Diseases (ILRAD) and the Food and Agriculture
Organization (FAO) project URT/86/022 between 1986 and 1990 on Unguja Island,
Zanzibar, the government decided to introduce immunization as another method for
the control of ECF in addition to acaricide application. Since the completion of the
trials, a total of more than 300 calves and adult cattle have been immunized.
Serological examination, using the indirect fluorescent antibody test, of samples
taken on day 28 after immunization showed that more than 98% of the immunized
animals had developed antibody titres against Theileria parva schizonts ranging from
1:200 to more than 1:5000. The animals immunized since the completion of the trials
did not suffer from anaemia which was a serious complication in the trials. The
anaemia was thought to have been caused by T. mutans parasitaemia and other tick
borne diseases because of unlimited exposure to ticks.
Cattle which were older than six months, including milking and pregnant cows,
had lower numbers of microschizonts detected in lymph nodes compared to younger
animals following immunization. Out of the 78 adult cows that were immunized in
the field, 14 (21%) had to be treated with parvaquone (Clexon, Wellcome) while 38
out of the 94 (40%) young stock had to be treated for immunization reactions. East
Coast fever immunization could be carried out safely at all stages of gestation and
there was no loss in milk production in the 35 dairy animals that were immunized
and studied.
The health status, plane of nutrition and absence of helminthiasis and intercurrent
diseases must be strictly verified before a decision is made to immunize an animal.
Further investigations are required on immunization of calves younger than six
months, the  effect of immunization on pregnancy and milk production and the
reproductive performance. The assessment of the socioeconomic impact of immuni-
zation is necessary and the need for immunization against Babesia bovis and other
tick-borne diseases, such as heartwater, T. mutans theileriosis and anaplasmosis, must
be considered in the planning of the immunization program.
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Theileriosis and other tick-borne
diseases in North Kivu, Zaire
M. Ndahiriwe
Projet d’Elevage Nord-Kivu
B.P. 269 Goma
Nord-Kivu, Zaire
The total cattle population in Zaire is estimated to be 1.4 million head, 45% are
located in the east and the northeast where East Coast fever (ECF) is known to occur.
Studies of the tick species and distribution in Zaire have shown that tick-borne disease
vectors are widespread in the country.
The mortality rate of young calves due to ECF in North Kivu is about 15–20% per
year, and the disease is severe, mainly in the low altitude areas (100–1800 m). The
situation is similar in the northeastern part where the Nioka Research Station
estimated that 30–70% of calves were dying from theileriosis. A trial using a form of
immunization against ECF was conducted by the laboratory of Gabu in 1954–1956.
The animals were artificially exposed to ticks infected with South African Theileria
parva strains. Chlortracycline (Aureomycin, Cyanimid) at a dose of 10 mg/kg was
administered intravenously to the animals on the day of tick application and treatment
was repeated daily until the pyrexia subsided. It was observed that it was necessary
to use ticks infected with local strain combinations in order to obtain a solid immunity.
In North Kivu, local breeds of cattle are more resistant to tick-borne diseases than
exotic cattle. The prevalence of tick-borne disease parasites estimated in 1980, by
blood smears examination, was 29.7% for theileriosis, 21.9% for babesiosis and
10.6% for anaplasmosis. Using enzyme linked immunosorbent assays for the detec-
tion of antibodies and antigens of tick-borne disease pathogens, the following results
were obtained from 256 sera screened.
Theileria mutans antibodies 9.7%
Theileria mutans antigens 37.3%
Anaplasma marginale antigens 55.4%
Theileria parva schizonts antibodies 21.0%
Babesia bigemina antibodies 22.5%
The titres were found to be higher in areas where strict tick control was not applied,
compared to those practising efficient tick control. However that difference appeared
less obvious for A. marginale.
Control is currently by acaricide application to the animals and treatment of
clinical cases. The difficulties experienced in applying these measures are the high
cost of acaricide, whereby 85% of the farmers cannot afford the expense, and the
inability to exercise strict cattle movement control.
East Coast fever and other tick-borne diseases are the major factors limiting the
productivity of livestock in eastern Zaire and improved strategies for control of these
diseases are required.
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East Coast fever immunization
in Eastern Province, Zambia
G.M. Lynen, L.H.C. Makala and W.M. Pas
Belgian Animal Disease Control Project
P.O. Box 510016
Chipata, Zambia
The Belgian Animal Disease Control Project (BADCP) started immunizations with
a local field isolate, Theileria parva (Katete), in the Eastern Province in December
1987. The field situation had been studied in previous years, the T. parva, East
Coast fever (ECF) incidence and tick activity were recorded, local strains were
isolated and cross-immunity trials were carried out. The first immunization results
were presented at the Workshop on Theileriosis held in Lilongwe in 1988 (Berkvens
et al., 1989).
PRESENT SITUATION
Tick population
Annual tick surveys during the months of January to March showed a slow
westward spread of Rhipicephalus appendiculatus. However, since 1989, this
extension has become less marked and the western boundary has remained at Tsitsi,
about 50 km west of Sinda. It is felt that the arrest in the extension of the range is
because ECF is now controlled and illegal cattle movement, in the wake of ECF
epidemics, has ceased. In 1991 a new extension of the tick’s range was noticed
northeast of Sinda and a distinct southwest migration into the Nyanje area occurred.
There have also been major extensions in the tick’s range towards the southern
(international) border of the province, as cattle were moved back into the area after
the cessation of hostilities.
The marginal areas of the tick’s range still carry low tick numbers (<1 tick/ani-
mal) except in the areas where ECF epizootics occur. In the rest of the area,
relatively high numbers of R. appendiculatus have been recorded over the past three
years, featuring a second generation of adults in May/June and a second cohort of
nymphs in August/September. Early rains in October 1989 resulted in abnormally
high tick counts throughout 1990. Regular tick control at this moment is almost
non-existent, except for some farmers who hand-spray their animals on a more or
less regular basis. Most government dip tanks stop operating as early as April/May
because of the high running costs, leaving susceptible animals fully exposed to the
second wave of ECF in the province.
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Local Theileria parva (Katete) isolate
The T. parva (Katete) field isolate as tick stabilate was sent to ILRAD for charac-
terization. Monoclonal antibody profiles and DNA characterization placed the Katete
isolate within the group of other Zambian T. parva (ECF type) isolates, and Katete-im-
munized cattle withstood subsequent challenge with the T. parva (Marikebuni) stock (R.
Bishop, P.R. Spooner, S.P. Morzaria, and T.T. Dolan, personal communication).
Immunization
Immunization campaigns have been extended gradually to all ECF-affected districts
of the Eastern Province. Serological and tick surveys preceded initiation of the
immunization campaigns in order to establish the range of enzootic stability of the
disease in the local cattle population. Immunization campaigns cover only the
indigenous animals except in Chadiza District where a commercial farm (extensive
ranching of Brahman cross-breds) has been included in the program.
To date 50,076 calves have been immunized (Table 1). Calves are immunized from
three to four weeks up to one year of age at the start of the program and, afterwards,
only calves up to four to five months are presented.
Campaigns are carried out in three periods: the main campaign runs from late
October until January for the main calf crop, with subsequent smaller campaigns
conducted in April–May and June–July. At first, the intention was to carry out the
campaigns before the highest field challenge which occurs in December–January and
in May–June. However, experimental trials have shown that (i) immunized animals
challenged with a known lethal dose as early as day 12 after immunization showed
an even better response to the immunization (i.e. lower parasitaemias and earlier
seroconversion) and (ii) animals infected with a known lethal dose could still be
successfully immunized or treated as late as day 12 after initial infection, using the
parotid gland swelling as the criterion for intervention (Belgian Animal Disease
TABLE 1. Number of calves immunized between December 1987 and August 1991
in East Coast fever-affected districts.
1987–89 1990 1991 District Overall
District calf crop calf crop calf crop total attendance %
Chipata 17,357 6,641 2,785* 26,783† 82
Chadiza 0 7,268 1,580* 8,848 84
Katete 0 6,466 3,161* 9,627 74
Lundazi 0 3,042 1,776* 4,818 81
*Totals until August 1991.
†Represents 60% of the cattle population in the district.
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Control Project, unpublished data). The highest incidence of treated cases were found
in the April–May campaigns.
The stabilate is produced at the Provincial Veterinary Laboratory at a 1/10 dilution
to economize on storage facilities, i.e. liquid nitrogen and containers. At present, a
total of 60,000 doses is stored in liquid nitrogen at the Provincial Veterinary Labora-
tory. The final 1/100 dilution (0.1 tick/dose) is prepared at the crush pen, producing
an equivalent of either 20 or 60 doses, depending on the number of calves brought
for immunization. A single dose of long-acting tetracycline (Terramycin LA, Pfizer)
at a rate of 20 mg/kg liveweight is administered. All calves below 50 kg liveweight
receive a minimum dose of 5 ml Terramycin LA. Since only newborn calves are
presented in the June–July campaign, the cost of tetracycline is significantly lower
compared to the other campaigns (Table 2).
A cold chain has been established at district level. This entails deep freezers to
store the medium used for dilution of the stabilate in the field and liquid nitrogen
containers holding the stabilate. The latter are only in use during the actual cam-
paigns. The campaigns are organized from the district veterinary offices by either the
district veterinary officer or the district livestock officer, under supervision of a
project member. All district laboratories have been furnished with basic diagnostic
equipment. The veterinary assistants have been issued with a motorbike to assist them
to carry out their duties.
All calves are ear-tagged prior to or at the time of the immunization to allow a
proper evaluation of the exercise at the end of the season. Anthelmintics are given to
calves in poor condition (highest incidence during the June–July campaign). Clinical
TABLE 2. Number of calves immunized and treated in the 1990–1991 immunization
campaigns together with usage of Terramycin LA.
Immunization Number Number Percentage Calves/100 ml
District campaign immunized treated treated Terra LA
Chipata Nov–Jan 3,801 71 1.9 14
April–May 1,145 43 3.7 15
June–July 1,637 64 3.9 17
Chadiza Nov–Jan 2,462 32 1.3 11
April–May 552 47 8.5 11
June–July 1,028 58 5.6 17
Lundazi Nov–Jan 3,042 38 1.9 11
April–May 914 50 3.7 13
June–July 862 19 3.9 17
Katete Nov–Jan 3,263 7 0.2 11
April–May 1,523 13 0.9 11
June–July 1,638 2 0.1 16
Overall 21,867 444 2.0 13
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cases of ECF are treated with parvaquone (Clexon, Coopers) and this drug is provided
to the veterinary assistants for follow-up treatments (Table 2). Cattle owners with
calves below the age of three weeks that are treated for ECF or immunized are advised
to present these calves again during the next campaign. Records are kept for all
ear-tagged animals, indicating whether or not they were present at the time of the
immunization and whether they were immunized or treated. A duplicate of this list
is given to the veterinary assistant for each area. Meetings at district level are
organized with all veterinary assistants after each campaign to discuss the exercise.
After finishing the immunization season, a follow-up census is organized in Au-
gust–September to record the fate of immunized and non-immunized calves.
RESULTS
Indigenous animals
Results are given for Chipata District as detailed records have been kept there over
the last three years.
• To date no breakthrough of a field strain has been recorded in the immunized
animals. In May 1988 a breakthrough was suspected, but isolation of the field strain
and subsequent cross-immunity trials showed that full protection existed between
the Katete stock and the field isolate.
• A follow-up of heifers from the 1987 immunization showed normal calving rates.
• Calf mortality has been reduced drastically from an average of 30–40% (figures
from sentinel herds 1982–1988) to 2.5–3.5% for immunized calves. At the same
time a distinct shift in causes of mortality was noted: ECF accounts for approxi-
mately 15% of the mortalities in immunized animals (compared to 85% in non-
immunized calves), whereas mortalities caused by management-related problems
increased from 12% in non-immunized calves to about 80% in immunized calves
(Table 3). Other tick-borne diseases, sweating sickness and trypanosomiasis play
a minor role in both immunized and non-immunized calves (Table 3).
• The reduction in calf mortality for the immunized population was accompanied by
a steady decrease in calf mortality in the non-immunized population to only 14.7%
in 1991 (Table 3). Results of the dissection of field ticks, to examine for any effect
of immunization on tick infection rates, showed a similar steady decrease but these
results are equivocal as mixed or other Theileria parasites cannot be discriminated.
• During the period 1987–1991 the total cattle population in the district increased
by 38%, from 33,097 to 45,770 head, and the demand for work oxen was catered
for. In cooperation with the Cold Storage Board (CSB) of Zambia, a joint venture
was started in late 1990 allowing veterinary assistants to act as buyers in the field
in order to increase the off-take of beef from the rural areas. Cattle slaughter
numbers (CSB and private butchers) increased from 1.5% in 1990 to 4.5% of the
total population in 1991 (Table 4).
COUNTRY REPORTS
19
Commercial farm
The commercial farm practices extensive ranching with about 1500 head of Brahman
cross-breds, producing 500 calves annually. Ticks and tick-borne diseases have been
controlled by conventional dipping but increasing cost of acaricides made the farmer
consider alternative methods of control.
The objective of this trial was to investigate the effects of relaxing conventional
tick control on other tick-borne diseases after immunization against ECF. Frequent
dipping using dioxathion (Altik), cypermethrin (Barricade), amitraz (Triatix) and
recently chlorfenvinphos (Steladone), did not prevent clinical cases of theileriosis,
babesiosis and occasionally heartwater occurring, especially at the beginning of the
dry season. Resistance to cypermethrin resulted in a severe outbreak of babesiosis in
1987. Weekly tick collections showed the presence of low numbers of R. appendicu-
latus and the regular appearance, in higher numbers, of Boophilus microplus and
Amblyomma variegatum.
TABLE 3. Percentage mortality in immunized and non-immunized calves and causes
of mortality (August 1991 census).
Percentage mortality
1989 1990 1991
Non-immunized calves 29.4% 17.9% 14.7%
Immunized calves 3.2% 2.7% 3.6%
Causes of mortality 1990–91 season
Non-immunized Immunized
ECF 544 (85.5%) 36 (15.1%)
Other TBD 13 (2.0%) 2 (0.8%)
Sweating sickness 0 (0 %) 4 (1.7%)
Trypanosomiasis 3 (0.5%) 2 (0.8%)
Helminthiasis* 42 (6.6%) 94 (39.4%)
Management* 20 (3.1%) 72 (30.1%)
Accidents* 15 (2.3%) 29 (12.1%)
637 239
Unconfirmed 15 27
Total 652 266
Census Population 4,438 7,435
% mortality overall 14.7% 3.6%
% ECF mortality overall 2.3% 0.5%
*Combined as management-related problems.
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In the experiment, 88 animals (44 calves of two to five months of age, with their
dams) were immunized and herded separately. At the start of the experiment, animals
had no antibodies to T. parva schizont antigen and moderate T. mutans and Anaplasma
marginale titres. Only 3% of the animals showed antibody titres against Babesia.
Dipping was stopped at the start of the trial and animals were given prophylactic
treatments with imidocarb dipropionate (Imizol) every seven weeks over the next five
months. Theileria parva (Katete) was used at a 1/100 dilution for immunization and
the cattle were monitored weekly.
All except two animals developed antibodies. The non-reactors were a dam and a
calf and it remains doubtful whether they were immunized. A very high number of
both cows and calves remained positive for antibodies up to six months after
immunization, despite the fact that no substantial field challenge was present. One
adult animal required treatment for ECF four months after immunization. The calf
that remained negative for T. parva died seven months later of ECF, its dam is still
alive but has not developed antibodies. After stopping prophylactic coverage with
imidocarb in August, no Babesia cases were recorded and serological results for
November showed a high prevalence of antibody titres of both B. bigemina and B.
bovis. One cow died in July 1991 from trypanosomiasis.
It has been agreed with the farmer to start a new trial using last year’s calf crop
(1990), based on immunization against ECF and imidocarb blanketing, to establish
the length of prophylactic coverage (number of treatments) necessary to safeguard
the animals against clinical babesiosis for their first year after immunization. The
first experiment raises hopes that enzootic stability may be re-established in a short
period of time.
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TABLE 4. Annual changes in cattle population in Chipata District during the period
1985–91, together with numbers of animals slaughtered in 1990 and 1991 (Janu-
ary–August).
Year 1985 1986 1987* 1988 1989 1990 1991
Cattle population 33,534 32,258 33,097 35,677 41,652 44,199 45,770
Percentage change –3.8 +2.6 +7.8 +16.7 +6.1 +3.6
Animals slaughtered 811 1994
Percentage increase (8.0) (8.0)
(slaughtered animals included)
*Start of the immunization campaigns in December 1987.
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DIAGNOSIS AND CONTROL
Current methods for diagnosis
of tick-borne diseases
J.A. Lawrence
Project GCP/RAF/259/DEN
Central Veterinary Laboratory
P.O. Box 30750
Lilongwe, Malawi
The methods of diagnosis of tick-borne diseases are described in a field manual
published by FAO in 1984. The usual method of detection of tick-borne disease
organisms is by microscopic examination of smears of blood, lymph node, spleen or
brain stained with Giemsa’s stain. Its advantages are that the specimens are easy to
collect, transport and preserve, it requires no sophisticated equipment, other than a
microscope, it can be carried out by relatively unskilled personnel and its accuracy
can  easily be  monitored. The  disadvantages  are  the  difficulty  in  differentiating
between a scanty parasitaemia/parasitosis in a clinically ill, dead or carrier animal
and the difficulty in differentiating between species of parasites of different patho-
genicity, especially Theileria species. Other methods used occasionally for detecting
organisms are isolation by inoculation of animals or in cell cultures.
The standard system for the detection of antibodies to tick-borne diseases is by the
indirect immunofluorescent antibody test (IFAT), using whole parasites in blood or
from cell culture as antigen. Its advantages are that the antigens are easy to prepare,
the test can be standardized for all tick-borne diseases, antibodies detected by the
IFAT are very persistent after infection and the test is usually highly specific, although
there may be some cross-reaction between related species. The major disadvantages
are that it is very laborious and the interpretation is subjective. It is also difficult to
achieve consistent results with Anaplasma. Other tests are available for Anaplasma
but they too have disadvantages.
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New methods for diagnosis and characterization
of tick-borne disease parasites
S.P. Morzaria
International Laboratory for Research on Animal Diseases
P.O. Box 30709
Nairobi, Kenya
Tick-borne diseases of cattle caused by the protozoal and rickettsial parasites of the
genera Theileria, Babesia, Anaplasma and Cowdria are a great constraint to livestock
development in Africa and other regions of the world. Accurate diagnosis of these
organisms is essential in epidemiological studies and in planning control strategies.
The currently available diagnostic methods are based on the identification of organ-
isms in Giemsa-stained smears or detection of specific antibodies in serum. Both
these methods are relatively insensitive and subjective. Therefore, newer tests, with
higher sensitivity and specificity, using reagents produced by molecular biological
techniques are being developed. For specific identification of parasites in cattle, DNA
probes show great promise. For example, unique DNA sequences from the genomes
of T. parva, T. mutans, T. taurotragi, T. buffeli, B. bigemina, B. bovis, A. marginale
and C. ruminantium have been identified, cloned and used as probes to provide
accurate identification of these parasites. The sensitivity of DNA probes can be
greatly enhanced by use of the polymerase chain reaction (PCR) technique, which
enables specific amplification of DNA by approximately a million-fold. It is expected
that advances in PCR technology, and the use of non-radioactive probes, will allow
wider application of the DNA-based diagnostics. DNA-based methods have been
developed also for finer differentiation of parasite stocks and strains within a species.
This has been exploited, particularly for T. parva, and the methodology developed
for this parasite can be used to define and characterize other tick-borne parasites.
Rapid progress is also being made in improving the currently available serological
tests. Improved enzyme-linked immunosorbent assays (ELISAs) based on conserved
parasite-specific antigens offer the best option to replace the currently used tests.
Parasite specific monoclonal antibodies have been utilized in antigen and antibody
detection assays to identify both the presence of an infection as well as exposure to
an infection. The ELISAs have higher specificity and sensitivity than the previously
used serological tests. Genes encoding the conserved and specific antigens recog-
nized by these monoclonal antibodies are  being cloned and expressed, and the
recombinant antigens provide well-defined antigens for the standardization of assays.
These assays can then be utilized to provide reliable information on epidemiological
studies within and between countries. It will also mean that the use of experimental
animals for production of antigens and antibodies can be greatly reduced.
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Current vaccines for tick-borne diseases
F.L. Musisi, J.A. Lawrence, S.P. Kamwendo and J. Malika
Tick-borne Diseases Vaccine Production Centre
P.O. Box 30750
Lilongwe 3, Malawi
There are four major tick-borne livestock diseases—anaplasmosis, babesiosis, theil-
eriosis and heartwater. On recovery from a primary infection with any of the parasites
causing these diseases, cattle become immune to homologous challenge. Tick fever
vaccines refer to Anaplasma centrale, Babesia bovis and B. bigemina blood vaccines.
Anaplasma centrale (which provides protection against the pathogenic A. marginale)
and B. bovis parasites are attenuated by rapid serial passage in splenectomized calves
before starting vaccine production. Babesia bigemina parasites are attenuated by
passage in intact calves every three months followed by splenectomy of the calf three
months after infection and collection of the parasites for future vaccine production.
The two major theileriosis pathogens for which vaccines are prepared are Theileria
annulata causing tropical theileriosis and T. parva causing the East Coast fever
(ECF)/Corridor disease/Zimbabwean theileriosis complex. The tropical theileriosis
vaccine is prepared from T. annulata-infected lymphoblastoid cells grown and attenu-
ated by passage in vitro, while the vaccine for ECF/Corridor disease/Zimbabwean
theileriosis consists of T. parva sporozoites from infected ticks prepared as stabilates
and used simultaneously with tetracycline treatment. The vaccine in common use for
heartwater is Cowdria ruminantium-infected blood from sheep but an alternative
vaccine prepared from infected Amblyomma nymphae can be used.
All these tick-borne disease vaccines are live and their ability to engender immu-
nity depends on the establishment and multiplication of the parasites in the animal.
Consequently, maintenance of infectivity during preparation and use is essential.
Infectivity can be adversely affected by fluctuations in temperature and the chemical
environment of the parasites. Precaution must be taken to avoid such fluctuations. All
these vaccines are best stored at –196 C in liquid nitrogen where they have an
essentially infinite shelf-life. The tick fever vaccines in addition can be supplied as
chilled vaccines with a usable life of seven days in the field.
Vaccine failure can occur as a result of either a failure to infect the animal or a lack
of immunogenicity. Use of a highly infective dose, application of conservative limits
on the shelf-life and education of the users would overcome failures due to a failure
to infect. The choice of appropriate parasite stocks and attention to the number of
passages a parasite has been subjected to would minimize failure due to lack of
immunogenicity. A variety of non-cross-protecting immunogenic strains and possible
antigenic drift in T. parva complicate decisions on cost-effective vaccine production.
Also, with live vaccines there is always a potential risk of developing acute disease,
dissemination of other infectious agents, such as bovine leucosis, and sensitization
of animals to blood and tick components.
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Novel vaccines against tick-borne diseases
A.J. Musoke
International Laboratory for Research on Animal Diseases
P.O. Box 30709
Nairobi, Kenya
The vaccines available for the control of Anaplasma marginale, Babesia bigemina,
B. bovis, Theileria parva, T. annulata and Cowdria ruminantium are all live. This
presents logistical problems in terms of delivery because of the requirement for a
cold chain to maintain viability and immunized animals become carriers of the
vaccination parasites. It is therefore necessary to develop alternative vaccines to
circumvent these disadvantages. To this end antigens which may induce protective
immune responses are being isolated and characterized.
Antigens which provoke protective responses have been identified for B. bigemina
and B. bovis and these are of 58 and 42 kDa, respectively. For A. marginale three
antigens of 105, 86 and 36 kDa have been identified but research has concentrated
on the 105 kDa antigen. The genes encoding the antigens of the three parasites have
been expressed in various expression vector systems and recombinant antigens are
presently being tested for their immunogenicity in cattle. Work on antigens evoking
antibody responses to the two Theileria organisms has taken precedence over those
inducing cellular responses because of the difficulties involved in identifying the
latter antigens. Antigens identified so far include the 67 kDa and the polymorphic
immunodominant (PIM) antigen for T. parva sporozoites and the 85 kDa complex
for T. annulata. The gene encoding the T. annulata p85 complex has been expressed
in the pGEX expression system and the recombinant antigen is presently being tested
for immunogenicity in cattle. The gene encoding T. parva p67 has been isolated and
characterized while the gene encoding PIM is yet to be identified. The p67 gene has
been expressed in pMGI, a derivative of the pAS vector system, where it is fused to
the first 85 amino acids of the non-structural protein of influenza virus A. The
recombinant antigen induced high titre neutralizing antibodies in cattle and protected
six of nine animals against homologous challenge and 6 of 11 against heterologous
challenge.
Taken together the results are encouraging and pave the way for development of
novel vaccines against these important tick-borne diseases. It is envisaged that when
the genes encoding the relevant antigens are isolated and characterized, an attempt
will be made to package them in one vector, such as Salmonella, for delivery to cattle.
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Vaccines against ticks
A.S. Young
International Laboratory for Research on Animal Diseases
P.O. Box 30709
Nairobi, Kenya
Although no commercial vaccines against ticks are available there are a number of
active research programs investigating potentially protective antigens, particularly in
Australia and Kenya. It is thought that tick vaccines would be useful measures to
integrate into control programs for ticks and tick-borne diseases in Africa.
The possibility of developing tick vaccines is supported by observations from the
field that individual cattle or breeds of cattle feed fewer ticks than others. Acquired
resistance is an immunological phenomenon by which the animal develops an
immunity after exposure to tick infestation and this is under genetic control. In
Australia, it has been possible to breed cattle for resistance against Boophilus
microplus infestation. In Africa, where several economically important tick vectors
of disease occur in any locality, breeding such resistant cattle might be difficult.
Research has shown that animals can be immunized against tick infestation using
crude tick antigens. These antigens can be divided into unconcealed antigens (anti-
gens to which cattle are normally exposed during tick infestation) and concealed
antigens (those to which cattle are not normally exposed during tick infestation).
Unconcealed antigens include antigens from the cuticle, salivary glands or salivary
gland secretions. Concealed antigens that have been used to date have been proteins
located on the gut epithelium of the tick. Most progress has been made by two groups
in Australia working on concealed antigens of B. microplus which have been purified
and  the  genes responsible used to produce recombinant antigens. In laboratory
experiments, immunization using these recombinant antigens can reduce B. micro-
plus feeding success on cattle by 90%. However problems exist since not all stocks
of B. microplus appear to have a particular antigen and so immunization is not
universally successful. A further disadvantage of this approach is that the antigen is
concealed so no natural boosting can occur.
The International Centre of Insect Physiology and Ecology (ICIPE) in Kenya is
studying the effects of both unconcealed and concealed antigens for immunizing
cattle against Rhipicephalus appendiculatus infestation with some success.
It is likely that a successful vaccine against ticks will have to contain several
different antigens to be effective.
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EPIDEMIOLOGY
AND MODELLING
The ecology of the free-living stages of
Rhipicephalus appendiculatus with reference
to computer simulation modelling
D.L. Berkvens
Institute for Tropical Medicine
Nationalestraat, 155
B-2000, Antwerpen
Belgium
The developmental kinetics of Rhipicephalus appendiculatus are well understood and
can be modelled satisfactorily. Simulating the phenology of this species, however,
still presents formidable problems. The principal reason for the poor performance of
most simulation models with respect to the situation in Southern Africa appears to
be the failure to take into account behavioural diapause entered by adult ticks after
moulting. In order to have any degree of success when attempting to understand the
population dynamics of R. appendiculatus, the following parameters must be consid-
ered: (i) the environmental conditions that induce diapause, (ii) the conditions, both
environmental and inherent to the tick, that maintain diapause and (iii) the relative
benefits offered by the state of diapause.
Regular tick collections and behaviour studies under quasi-natural conditions in
the Eastern Province of Zambia indicated that the phenology of R. appendiculatus
was a result of an intricate interplay between the environmental conditions, the tick’s
diapausing behaviour and its body size. The behavioural studies demonstrated that a
diapause is induced in newly moulted adults when the photoperiod falls below a
threshold, provisionally identified as 11 hr 45 min. The results of these studies also
indicated that, in the Eastern Province of Zambia, diapause was not terminated by
means of a photoperiodic cue, but rather because the adults could not maintain their
diapause due to their increasing (physiological) age. Given a rudimentary model of
the diapausing behaviour, the species’ phenology in the Eastern Province of Zambia
can be understood by taking into account the developmental kinetics governed by the
prevailing temperatures. However, at this point the overriding effect of the body size
becomes obvious and the resulting simulation model quickly becomes prohibitively
complex.
If computer simulation models are to be used to further our understanding of the
phenology of R. appendiculatus, an effort will have to be made to obtain basic data
concerning the tick’s body size, its inheritance and its effect on population dynamics.
Furthermore, the exact mode of maintaining diapause and the relative benefits of this
diapause must be elucidated. Even then it must be realized that `real-life’ simulations,
beyond an attempt to understand observations made with regard to the species’
ecology, may not be possible in the near future.
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DISCUSSION ON TICKS, DIAPAUSE, MODELS AND CONTROL
The discussion was led by Drs. Dirk Berkvens, Andy Norval, Rupert Pegram and
Alan Young and attended by about 25 participants to infection. The initial focus of
the discussion was on two recent papers (Lawrence, 1991 and Norval et al., 1991) on
the epidemiology of theileriosis in Southern Africa. In these papers the case was
argued for vector population dynamics and susceptibility of vector populations as
major influences in the disease expression. It was postulated that vigorous tick control
and unfavourable climatic conditions lead to the extinction of non-diapausing
Rhipicephalus appendiculatus populations that may have been introduced from East
Africa. The hypotheses were challenged by a case put forward by Pegram and
Berkvens which was prepared for the workshop. The outcome of the discussion was
a much better understanding by the participants of tick population dynamics and the
role and nature of behavioural diapause (also from the preceding paper by Berkvens).
A series of laboratory and field experiments was agreed to examine southern and
eastern African (close to the equator) tick behaviour and survival in each others’
environment to test some of the hypotheses.
The discussion then moved to the inheritance of size in R. appendiculatus and its
influence on longevity of ticks and its role in Theileria parva transmission. This too
will be the subject of some studies. The discussion finally turned to a general
consideration of available models, their limitations and the ultimate possibility of a
predictive model for use in determining national disease control strategies. It was
generally felt that while some models in use for ticks were fairly efficient in defined
circumstances, the few developed for tick-borne diseases were not good. It was agreed
that much more work is required on existing models (Climex, T3, Lonestar, ECFX-
PERT, ICIPE and those of Berkvens and Medley) to improve them and to develop
new models that might also incorporate production data.
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Assessment of the impact of control
measures against theileriosis
B.D. Perry, J.J. Curry and A.W. Mukhebi
International Laboratory for Research on Animal Diseases
P.O. Box 30709
Nairobi, Kenya
Theileriosis caused by Theileria parva and transmitted by the tick Rhipicephalus
appendiculatus is widely prevalent in 11 countries of eastern, central and southern
Africa, where it presents a major constraint to the development of the livestock
industry. The disease is of particular significance in taurine and taurine-zebu cross
cattle and in more intensive livestock production systems that limit natural exposure
of calves to infected ticks, and thus the development of endemic stability. With the
availability of effective procedures for the immunization of cattle against theileriosis
using broadly immunogenic stocks of T. parva in the infection-and-treatment method,
and the prospect of effective sub-unit vaccines for all the major tick-borne diseases
on the horizon, there is an increasing awareness of the importance of assessing the
impact of controlling theileriosis and other tick-borne diseases for three main reasons:
1. To assist governments, farmers and donor agencies in decisions on the efficient
allocation of resources for tick-borne diseases control.
2. To define appropriate target populations for immunization and develop mech-
anisms for sustainable immunization programs.
3. To assess the long-term consequences of removing or reducing the constraint
of tick-borne diseases from farming systems.
The Socioeconomics Program at ILRAD, in collaboration with scientists in na-
tional research organizations in the region, is carrying out research into the impact
of theileriosis and its control in the following broad areas.
ECONOMIC IMPACT
Regional, national (Uganda) and farm-level (Kaloleni Division, Kenya) assessments
of the cos t of the i le r ios is and the economic benefi ts of applying
infection-and-treatment immunization have been undertaken, and further studies
(Kenya, Zimbabwe, Uasin Gishu District of Kenya) are under way or planned. The
annual regional economic cost of theileriosis has been estimated to be US$ 168
million, a figure which includes an estimated annual mortality of 1.1 million cattle
(Mukhebi e t a l . , 1992) . The benefi t s o f the i le r ios i s contro l by the
infection-and-treatment method of immunization have been estimated to be high,
particularly in taurine and taurine-zebu cross cattle, with benefit:cost ratios in the
range of 2:1–17:1 (Mukhebi et al., 1989; Mukhebi et al., 1992; ILRAD, 1992).
Further studies by ILRAD of financial and economic impacts of theileriosis control
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in different livestock production and theileriosis risk circumstances are under way in
several countries of the region in collaboration with the relevant national research
institutes.
SOCIAL AND ENVIRONMENTAL IMPACT
Methodologies for characterizing livestock production systems on the basis of the
likely differential impact of disease control have been developed in Kenya. In Kilifi
District of Coast Province, livestock production systems were classified according to
agro-ecological zone, cattle type, and grazing system (ILRAD, 1991). In the highland
Uasin Gishu District, farm size was found to be associated with cattle herd size and
management practices, and was used as a grouping variable in order to examine
inter-farm variation in access to economic and productive resources, in food distri-
bution and in disease risk (Huss-Ashmore and Curry, 1992; Delehanty, 1991). Studies
are also under way to evaluate the nutritional impact of disease control, and incorpo-
rate this assessment with economic impact. For small-scale intensive dairy production
at the Kenya Coast, the milk from an additional dairy cow surviving due to immuni-
zation against theileriosis was estimated to provide an average household with an
additional 498 Kcals per day, or Kshs 16.13 if the milk was sold. The annual profit
from one dairy cow surviving could furnish 289–466 man-days of a balanced diet
composed of commonly-eaten foods. (Huss-Ashmore, 1992). Environmental impact
studies are in the planning stage. However, a conceptual model and hypotheses to be
tested have been developed. Field work has begun at one site in eastern Africa, and
is planned for other sites in southern, central and West Africa (Reid et al., 1993).
EPIDEMIOLOGICAL IMPACT
A combination of stratified serological studies and sentinel calf studies have been
used in two districts of Kenya to identify the target populations for theileriosis
immunization based on disease risk. In sentinel calf studies in Kilifi District of Coast
Province, Kenya, the interval between first exposure to natural challenge and the
acquisition of T. parva infection in a group of 15 taurine cross calves was found to
range from 12–98 days. The incidence of ECF in this group was 88% and the case
fatality 66% in spite of the availability of chemotherapy. This demonstrated the high
priority for immunization of taurine cross calves and the narrow window of time
within which immunization should take place. In a cross sectional serological study
of dairy cattle in the same district, antibody prevalence rates to T. parva varied by
agro-ecological zone, cattle type, age group and livestock management system from
85% in free-ranging zebu cattle in the wetter coastal lowland zone to less than 58%
in zero-grazed dairy cattle in the same zone (S.H. Maloo, W. Thorpe, J.M. Katende,
G. Kioo, V. Nantulya, S. Williamson, and B.D. Perry, in preparation). In a further
study of zebu cattle in the district, antibody prevalence rates ranged from 22 to 85%
across agro-ecological zones, suggesting differences in the justification for immuni-
zation against ECF in different zones (Deem et al., 1993).
Data from these and other studies are being used to model the epidemiology of
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tick-borne diseases (Medley et al., 1993) and the impact of control measures under
different circumstances (R.A.I. Norval, B.D. Perry, M.I. Meltzer, R. Kruska and T.H.
Booth, in preparation; B.D. Perry, R.L. Kruska, R.A.I. Norval, S.E. Randolph, D.J.
Rogers and U. Ushewokunze-Obatolu, in preparation).
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STRATEGIES
Perspective of the Organization of African
Unity-Inter African Bureau for Animal
Resources (OAU-IBAR)
W.N. Masiga
Organization of African Unity
P.O. Box 30786
Nairobi, Kenya
The Organization of African Unity-Inter African Bureau for Animal Resources
(OAU-IBAR) is guided by the OAU member states when drawing up the priority list
for the livestock diseases to be controlled on the continent. Until February 1989, the
priority list included, in descending order, rinderpest, tsetse and trypanosomiasis and
contagious bovine pleuro-pneumonia (CBPP). Since February 1989, tick and tick-
borne disease control has been added to the list.
OAU-IBAR will collaborate very closely with FAO and ILRAD in the area of ticks
and tick-borne disease control. IBAR’s overall strategy is that the control of ticks and
tick-borne diseases should be on a regional basis.
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Perspective of the Southern African
Development Coordination Conference
(SADCC) Livestock Sector
M.V. Raborokwe
The Southern African Development Coordinating Conference
Department of Animal Health and Livestock Development
Private Bag 0032
Gaborone, Botswana
The Southern African Development Coordination Conference (SADCC) represents
a grouping of the ten majority-ruled southern African states. The individual country
disease priorities differ and even among the tick-borne diseases, individual country
priorities are not the same. However SADCC considers ticks and tick-borne diseases
as among the most important diseases in the region.
Ticks and tick-borne diseases are regional problems and there is in place a regional
project to try and address these problems. This project is the Regional East Coast
Fever and Heartwater Vaccines Production and Immunization Project based in
Lilongwe, Malawi, and Harare, Zimbabwe. The main objective of the project is to
create a self-supporting regional centre for the production of East Coast fever and
heartwater vaccines to control these major diseases in the region.
Current funding of the ECF component of the project is due to end in December
1991. Discussions with the United Nations Development Program (UNDP) on fund-
ing the project beginning in January 1992 are ongoing. The UNDP is, however, only
willing to consider funding the project if it is a priority project in SADCC, and if
other donors agree to co-financing arrangements.
This is a priority project for the SADCC Livestock Sector and we would like to
see it continue. Support is still required for the project to consolidate what has been
achieved and for SADCC to prepare to take it over. SADCC is indeed committed to
taking over the project, attaches great importance to it and would like to see it succeed.
It is envisaged that it will be a commercially self-sustaining vaccine production unit
selling vaccine to anyone willing to pay.
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Perspective of the International Laboratory
for Research on Animal Diseases (ILRAD)
M. Touré
International Laboratory for Research on Animal Diseases
P.O. Box 30709
Nairobi, Kenya
The International Laboratory for Research on Animal Diseases (ILRAD) was estab-
lished by the Consultative Group on International Agricultural Research (CGIAR) in
1973 with a global mandate to improve livestock disease control. Since its inception
it has worked on tsetse-transmitted trypanosomiasis and theileriosis caused by
Theileria parva.
ILRAD has four programs: Trypanosomiasis, Theileriosis, Epidemiology and
Socioeconomics and Cooperative Programs, Training and Information. ILRAD’s
Theileriosis Program is divided into three areas, epidemiology and biology, antigens
and vaccine development. The involvement with tick-borne diseases in the eastern,
central and southern Africa region is as a partner. ILRAD has been directly involved
with the implementation of the infection-and-treatment method of control on Unguja
and Pemba islands of Zanzibar and in Zimbabwe and has assisted national agricultural
research systems in other countries of the region with training of staff, provision of
diagnostic reagents and characterization of Theileria parva stocks. ILRAD’s current
research program is directed toward developing new vaccines against T. parva and
improved diagnostic and characterization reagents for tick-borne diseases.
ILRAD’s Epidemiology and Socioeconomics Program is developing methodolo-
gies for assessing the impact of disease control. It has selected two widely divergent
areas for this work, Kenya and Zimbabwe, and has had an association with the
Zanzibar T. parva immunization program in assessing the economic impact of the
program. Once developed, these methodologies will be made available to assist in
the assessment of the impact of control measures being implemented within the
region.
The third ILRAD program that contributes to tick-borne disease control in the
region is Cooperative Programs, Training and Information. This program is respon-
sible for the formal courses run regularly on diagnosis of haemoprotozoan diseases,
for specialist courses and for individual training. ILRAD’s Training and Information
Program will participate in discussions with national and regional projects to identify
the training needs at different levels so that it complements the training offered or
planned by the projects.
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RECOMMENDATIONS
Recommendations
• That a pre-investment phase be initiated for tick-borne disease control by immu-
nization based upon quality controlled vaccines produced on a commercial, cost
recovery basis and delivered in a sustainable manner.
• That a standing committee be formed to determine the standards for charac-
terization, infectivity, viability and potency testing of stabilates to be used for
Theileria parva vaccination and for blood vaccines for anaplasmosis, babesiosis
and cowdriosis.
1. The committee will meet to define its terms of reference which must be
approved by OAU, FAO and ILRAD.
2. The committee will have power to co-opt member(s) with specific technical
expertise.
3. The committee will have the power to review the vaccine production systems
in use in the region and to ensure compliance with the standards laid down.
4. The standards will be submitted to OIE for inclusion in the OIE Manual of
Standards.
5. The workshop nominated Drs. Chizyuka (Zambia), Dolan (ILRAD, Kenya),
Irvin (ODA, Kenya), Pegram (FAO, Zimbabwe), Musime (OAU, Kenya) and
Musisi (FAO, Malawi) to the committee.
• That existing models for ticks and tick-borne diseases should be more widely
employed and evaluated, and that new models should be constructed as necessary,
to assist in designing more effective control measures.
1. The ultimate objective is predictive models that can be used by disease control
planners in designing strategy.
2. These models should be assembled, used and refined in Africa.
• That a network be established to provide effective information exchange on ticks
and tick-borne diseases within the region.
1. The network will be run by a committee and will be supported by FAO.
2. The network be based in Malawi and will use the existing newsletter produced
by the FAO-sponsored vaccine projects as a basis for its publications.
3. The workshop participants nominated Drs. Mfitilodze, (University of Malawi),
Lawrence (FAO, Malawi), Musime (OAU, Kenya) and Musisi (FAO, Malawi)
to the committee.
• That the training needs of each country should be identified by the national and
regional donor-supported projects in collaboration with NARS. The courses
required to meet these needs should be discussed and harmonized between NARS,
donor-funded projects, ILRAD and other IARCs.
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Definition of technical or experimental death
The need for this definition is essentially humanitarian and is intended to apply in all
experimental situations. There is no scientific justification for allowing unnecessary
suffering in animals when immunization fails to prevent severe disease or when
control animals are used to indicate that a stabilate, controlled tick or natural
challenge is infective.
Technical or experimental death is defined as a state of severe disease in which it
can be reasonably expected that an animal will die unless treated. For experimental
purposes animals in this category will be recorded as having had a `severe reaction’
(Anon, 1989) and died but will be treated or euthanised.
In the laboratory, parameters such as parasitosis, fever, fall in total leucocyte count
and the clinical condition of the animal may be used to determine severe reaction and
therefore the state of technical or experimental death.
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CLOSING ADDRESS
Closing address
Hon. J.O. Bwangamoi
Deputy Minister of Agriculture, Animal Industry and Fisheries
Government of Uganda
Parliament Buildings
Kampala, Uganda
I am very happy to be here this afternoon to officiate at this closing ceremony of the
FAO/DANIDA review meeting and the OAU/ILRAD/FAO workshop on ticks and
tick-borne diseases.
I understand from the organizers that these two meetings have been in session for
six days. I have been informed that the participants at these meetings have involved
experts in tick and tick-borne disease control, directors of veterinary services, donors
and others interested in the tick and tick-borne disease problem.
I believe that the coming together of so many scientists like you has resulted in
valuable exchange of knowledge and experiences and will greatly help to pave the
way toward the establishment of practical, cost effective methods of controlling ticks
and tick-borne diseases in East and Central Africa.
The Government of Uganda attaches great importance to increasing the output of
animal products and livestock productivity in general through the improvement of
animal health, nutrition, husbandry and management. Effective control of disease is
a prerequisite to livestock development and the government therefore puts great
emphasis on eliminating disease in order to create a favourable environment for
production.
Ticks and tick-borne diseases are a major hindrance to livestock production in East
and Central Africa and Uganda as a member of the region appreciates the efforts being
made by the FAO and DANIDA program in combating these diseases. Your coming
together therefore to discuss and find solutions to a common problem is very
welcome.
I am informed that immunization trials against East Coast fever are going on in
the various countries of the region.
I am happy to note that, among others, the meetings recommended that future
projects should be designed to make available to national governments appropriate,
safe and cost-effective technologies for control of ticks and tick-borne diseases.
I would like to take this opportunity to express the gratitude of the Government of
Uganda to FAO and DANIDA for funding the program in tick and tick-borne disease
control in East and Central Africa. I also wish to thank OAU-IBAR and ILRAD for
the support they have given to Uganda in various aspects regarding the control of
ticks and tick-borne diseases.
I now have much pleasure in declaring the FAO/DANIDA review meeting and the
OAU-IBAR/ILRAD/FAO Ticks and Tick-borne Disease Control Workshop closed.
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